The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Romidepsin activity in T follicular helper(TFH)-phenotype PTCL versus non TFH treated on the same clinical trials.
 
Paola Ghione
No Relationships to Disclose
 
Neval Ozkaya
No Relationships to Disclose
 
Promie Faruque
No Relationships to Disclose
 
Neha Mehta-Shah
No Relationships to Disclose
 
Matthew Alexander Lunning
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Juno Therapeutics; Pharmacyclics; Seagen; TG Therapeutics
 
Jia Ruan
Honoraria - Acerta Pharma; Celgene; Janssen Research & Development; Seagen
Consulting or Advisory Role - Acerta Pharma; Janssen Research & Development; Seagen
Research Funding - Acerta Pharma; Celgene; Pharmacyclics; Seagen
 
Natasha Galasso
No Relationships to Disclose
 
Alison J. Moskowitz
No Relationships to Disclose
 
Ahmet Dogan
Consulting or Advisory Role - Celgene; Novartis; Oncology Specialty Group; Peerview; Roche; Seagen
 
Steven M. Horwitz
Consulting or Advisory Role - Celgene; Forty Seven; HUYA Bioscience International; Infinity Pharmaceuticals; Kyowa Hakko Kirin; Millennium; Seagen
Research Funding - ADC Therapeutics; Aileron Therapeutics; Celgene; Forty Seven; Infinity Pharmaceuticals; Kyowa Hakko Kirin; Seagen; Spectrum Pharmaceuticals; Takeda